仿制药的新定价模式,以确保欧洲的长期可持续竞争
Clement Francois1,2, Gabriela Gawlik3, Jorge Mestre-Ferrandiz4
1Aix Marseille University, Marseille, France.
Frontiers in pharmacology
|October 25, 2023
概括
对于面临价格侵蚀和成本上的欧洲仿制药,需要新的定价模式. 阶级定价和脱链价格显示出在非专利药品市场中可持续竞争的前景.
科学领域:
- 药物经济学 药物经济学
- 卫生政策 卫生政策
- 市场竞争市场竞争市场竞争
背景情况:
- 现有的定价政策和通货膨胀增加了仿制药的运营成本.
- 欧洲非专利药品市场的可持续竞争受到威胁.
- 需要探索仿制药的新定价策略.
研究的目的:
- 确定和评估欧洲零售仿制药的潜在定价模式.
- 分析所识别的模型的优缺点.
- 举例说明药品行业内外的定价模式.
主要方法:
- 进行了有针对性的文献审查.
- 与专家进行一对一的采访.
- 与来自五个欧洲国家的专家举行了联合咨询委员会会议.
主要成果:
- 确定了10种潜在的仿制药定价模型.
- 分级定价是一个可持续的解决方案,但需要市场监测基础设施.
- 价格脱和自动索引可以解决价格侵蚀和通货膨胀成本.
- 其他模式,如基于价值的定价和税收抵免,其实施潜力较低.
- 涉及患者费用的模式不太可能在社会上被接受.
结论:
- 新的仿制药定价模式必须考虑对创新药物和国家医疗保健系统的影响.
- 持续监测非专利药品市场竞争是必不可少的.
- 识别和减轻仿制药市场的可持续性风险至关重要.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
742
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
742
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Drug Nomenclature
1.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.8K
Drug Control Governance: Regulatory Bodies and Their Impact
163
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
163
Pharmacokinetic Models: Overview
733
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
733
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K


